128 related articles for article (PubMed ID: 10371355)
21. Interleukin 1 and interleukin 1beta converting enzyme (caspase 1) expression in the human colonic epithelial barrier. Caspase 1 downregulation in colon cancer.
Jarry A; Vallette G; Cassagnau E; Moreau A; Bou-Hanna C; Lemarre P; Letessier E; Le Neel JC; Galmiche JP; Laboisse CL
Gut; 1999 Aug; 45(2):246-51. PubMed ID: 10403737
[TBL] [Abstract][Full Text] [Related]
22. Positive and negative consequences of soluble Fas ligand produced by an antigen-specific CD4(+) T cell response in human carcinoma immune interactions.
Bergmann-Leitner ES; Abrams SI
Cell Immunol; 2001 Apr; 209(1):49-62. PubMed ID: 11414736
[TBL] [Abstract][Full Text] [Related]
23. [Expression and function of interleukin-18 in mouse dextran sulfate sodium colitis].
Wen ZH; Quyang Q; Zhang H; Yi ZH; Wang YF
Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Sep; 36(5):676-8. PubMed ID: 16235535
[TBL] [Abstract][Full Text] [Related]
24. Interleukin 18 and associated markers of T helper cell type 1 activity in coeliac disease.
Salvati VM; MacDonald TT; Bajaj-Elliott M; Borrelli M; Staiano A; Auricchio S; Troncone R; Monteleone G
Gut; 2002 Feb; 50(2):186-90. PubMed ID: 11788557
[TBL] [Abstract][Full Text] [Related]
25. Interferon-gamma sensitizes colonic epithelial cell lines to physiological and therapeutic inducers of colonocyte apoptosis.
O'Connell J; Bennett MW; Nally K; O'Sullivan GC; Collins JK; Shanahan F
J Cell Physiol; 2000 Dec; 185(3):331-8. PubMed ID: 11056003
[TBL] [Abstract][Full Text] [Related]
26. Fas ligand expression in primary colon adenocarcinomas: evidence that the Fas counterattack is a prevalent mechanism of immune evasion in human colon cancer.
O'Connell J; Bennett MW; O'Sullivan GC; Roche D; Kelly J; Collins JK; Shanahan F
J Pathol; 1998 Nov; 186(3):240-6. PubMed ID: 10211111
[TBL] [Abstract][Full Text] [Related]
27. Endogenous interleukin-18 modulates immune escape of murine melanoma cells by regulating the expression of Fas ligand and reactive oxygen intermediates.
Cho D; Song H; Kim YM; Houh D; Hur DY; Park H; Yoon D; Pyun KH; Lee WJ; Kurimoto M; Kim YB; Kim YS; Choi I
Cancer Res; 2000 May; 60(10):2703-9. PubMed ID: 10825144
[TBL] [Abstract][Full Text] [Related]
28. Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by Fas-Fas ligand- and perforin-induced tumor apoptosis, respectively.
Hashimoto W; Osaki T; Okamura H; Robbins PD; Kurimoto M; Nagata S; Lotze MT; Tahara H
J Immunol; 1999 Jul; 163(2):583-9. PubMed ID: 10395644
[TBL] [Abstract][Full Text] [Related]
29. Microflora reactive IL-10 producing regulatory T cells are present in the colon of IL-2 deficient mice but lack efficacious inhibition of IFN-gamma and TNF-alpha production.
Waidmann M; Allemand Y; Lehmann J; di Genaro S; Bücheler N; Hamann A; Autenrieth IB
Gut; 2002 Feb; 50(2):170-9. PubMed ID: 11788555
[TBL] [Abstract][Full Text] [Related]
30. Modulation of fas-ligand (Fas-L) on human microglial cells: an in vitro study.
Frigerio S; Silei V; Ciusani E; Massa G; Lauro GM; Salmaggi A
J Neuroimmunol; 2000 Jun; 105(2):109-14. PubMed ID: 10742551
[TBL] [Abstract][Full Text] [Related]
31. In vitro modulation of tumor progression-associated properties of hormone refractory prostate carcinoma cell lines by cytokines.
Sokoloff MH; Tso CL; Kaboo R; Taneja S; Pang S; deKernion JB; Belldegrun AS
Cancer; 1996 May; 77(9):1862-72. PubMed ID: 8646686
[TBL] [Abstract][Full Text] [Related]
32. Role of Fas/Fas ligand-mediated apoptosis in murine contact hypersensitivity.
Xu B; Bulfone-Paus S; Aoyama K; Yu S; Huang P; Morimoto K; Matsushita T; Takeuchi T
Int Immunopharmacol; 2003 Jul; 3(7):927-38. PubMed ID: 12810350
[TBL] [Abstract][Full Text] [Related]
33. Interleukin-18 mRNA, but not interleukin-18 receptor mRNA, is constitutively expressed in islet beta-cells and up-regulated by interferon-gamma.
Hong TP; Andersen NA; Nielsen K; Karlsen AE; Fantuzzi G; Eizirik DL; Dinarello CA; Mandrup-Poulsen T
Eur Cytokine Netw; 2000 Jun; 11(2):193-205. PubMed ID: 10903798
[TBL] [Abstract][Full Text] [Related]
34. Human pancreatic carcinoma cells secrete bioactive interleukin-18 after treatment with 5-fluorouracil: implications for anti-tumor immune response.
Carbone A; Rodeck U; Mauri FA; Sozzi M; Gaspari F; Smirne C; Prati A; Addeo A; Novarino A; Robecchi A; Bertetto O; Emanuelli G; Bellone G
Cancer Biol Ther; 2005 Feb; 4(2):231-41. PubMed ID: 15684607
[TBL] [Abstract][Full Text] [Related]
35. TL1A as a Potential Local Inducer of IL17A Expression in Colon Mucosa of Inflammatory Bowel Disease Patients.
Ślebioda TJ; Bojarska-Junak A; Stanisławowski M; Cyman M; Wierzbicki PM; Roliński J; Celiński K; Kmieć Z
Scand J Immunol; 2015 Oct; 82(4):352-60. PubMed ID: 26072972
[TBL] [Abstract][Full Text] [Related]
36. IL-18 translational inhibition restricts IFN-gamma expression in crescentic glomerulonephritis.
Garcia GE; Xia Y; Ku G; Johnson RJ; Wilson CB; Feng L
Kidney Int; 2003 Jul; 64(1):160-9. PubMed ID: 12787406
[TBL] [Abstract][Full Text] [Related]
37. Fas ligand expression in colon cancer: a possible mechanism of tumor immune privilege.
Zhang W; Ding EX; Wang Q; Zhu DQ; He J; Li YL; Wang YH
World J Gastroenterol; 2005 Jun; 11(23):3632-5. PubMed ID: 15962391
[TBL] [Abstract][Full Text] [Related]
38. Mucosal IL-10 and TGF-beta play crucial roles in preventing LPS-driven, IFN-gamma-mediated epithelial damage in human colon explants.
Jarry A; Bossard C; Bou-Hanna C; Masson D; Espaze E; Denis MG; Laboisse CL
J Clin Invest; 2008 Mar; 118(3):1132-42. PubMed ID: 18259614
[TBL] [Abstract][Full Text] [Related]
39. Down-regulation of IL-18 receptor in cancer patients: its clinical significance.
Kobashi K; Iwagaki H; Yoshino T; Morimoto Y; Kohka H; Kodama M; Nishibori M; Akagi T; Tanaka N
Anticancer Res; 2001; 21(5):3285-93. PubMed ID: 11848485
[TBL] [Abstract][Full Text] [Related]
40. Interleukin 18 enhances Fas ligand expression and induces apoptosis in Fas-expressing human myelomonocytic KG-1 cells.
Ohtsuki T; Micallef MJ; Kohno K; Tanimoto T; Ikeda M; Kurimoto M
Anticancer Res; 1997; 17(5A):3253-8. PubMed ID: 9413156
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
